Neuromyelitis Optica Program

What we do

The Neuromyelitis Optica Program at UT Southwestern is recognized as a world leader in the research and treatment of NMOSD including both aquaporin-4 antibody-positive patients and patients who are seronegative or have MOGAD. While all faculty members treat and manage patients with NMOSD, we collaborate with the Transverse Myelitis Association, Guthy-Jackson Charitable Foundation, and The MOG Project to offer comprehensive care to patients with NMOSD for individuals worldwide.